Use of Plasma Proteomics to Interrogate the Biologic Footprint of Ischemic Heart Disease in Heart Failure. Tavolinejad H, Chirinos JA. Mayo Clin Proc 2025;100:1095-1097.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tavolinejad H, Chirinos JA. Use of Plasma Proteomics to Interrogate the Biologic Footprint of Ischemic Heart Disease in Heart Failure. Mayo Clin Proc 2025;100:1095-1097.
PMID: 40610106